Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.11

-2.6%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (13248)	9/30/2004 8:26:48 PM
From: Ray Rueb	Read Replies (1) of 52153

Procrit and Epogen are the same drug, both made by AMGN 4. Procrit, $3.3 billion, anemia, Johnson & Johnson 6. Epogen, $3.1 billion, anemia, Amgen Inc. Both products are the same drug (Epoetin Alpha) manufactured by AMGN. Procrit is marketed by Johnson & Johnson because Amgen was a struggling Biotech and needed $300+ MM to bring Epoetin Alpha to market. In exchange J&J got a $5 bln a year market for anemia in cancer and Amgen got the $3 bln a year market for anemia in dialysis. Oh, yeah - AMGN also got the opportunity to become the number one biotech company. You all be careful out there Ray

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next